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OBJECTIVE—Polymorphic INS-VNTR plays an important role
in regulating insulin transcript expression in the human thymus
that leads to either insulin autoimmunity or tolerance. The
molecular mechanisms underlying the INS-VNTR haplotype-de-
pendent insulin expression are still unclear. In this study, we
determined the mechanistic components underlying the differen-
tial insulin gene expression in human thymic epithelial cells,
which should have profound effects on the insulin autoimmune
tolerance induction.
RESEARCH DESIGN AND METHODS—A repetitive DNA
region designated as a variable number of tandem repeats
(VNTR) is located upstream of the human insulin gene and
correlates with the incidence of type 1 diabetes. We generated six
class I and two class III VNTR constructs linked to the human
insulin basal promoter or SV40 heterologous promoter/enhancer
and demonstrated that AIRE protein modulates the insulin
promoter activities differentially through binding to the VNTR
region.
RESULTS—Here we show that in the presence of the autoim-
mune regulator (AIRE), the class III VNTR haplotype is respon-
sible for an average of three-fold higher insulin expression than
class I VNTR in thymic epithelial cells. In a protein-DNA pull-
down experiment, AIRE protein is capable of binding to VNTR
class I and III probes. Further, the transcriptional activation of
the INS-VNTR by AIRE requires the insulin basal promoter. The
VNTR sequence loses its activation activity when linked to a
heterologous promoter and/or enhancer.
CONCLUSIONS—These ﬁndings demonstrate a type 1 diabetes
predisposition encoded by the INS-VNTR locus and a critical
function played by AIRE, which constitute a dual control mech-
anisms regulating quantitative expression of insulin in human
thymic epithelial cells. Diabetes 60:336–344, 2011
I
nsulin plays a critical role in maintaining glucose
metabolism. Insulin deﬁciencies lead to hyperglyce-
mia and diabetes. Type 1 diabetes results from
speciﬁc and progressive autoimmune destruction of
pancreatic  cells in the islets of Langerhans. Insulin not
only plays a critical role in glucose homeostasis, but also
presents itself as a primary autoantigen in type 1 diabetes
(1,2). A polymorphic region containing variable numbers
of tandem repeat (VNTR) is located 5-upstream of the
human insulin gene, which in combination with the prox-
imal insulin basal promoter, modulates both -cell re-
sponse to glucose and the expression of proinsulin in the
thymus (3–5). This locus (INS-VNTR/IDDM2) is important
in determining genetic susceptibility to diabetes (6–8).
The INS-VNTR locus consists of a 14–15 base pair (bp)
consensus sequence unit (ACAGGGGTCTGGGG) with
slight variations of the repeat subtype units. The number
of repeats ranges from 26 to more than 200, but differences
in length are not randomly distributed. Intensive linkage
analysis on different population cohorts has offered evi-
dence to support that individuals exhibiting class I VNTRs
are predisposed to type 1 diabetes, whereas those with
class III VNTRs are provided dominant protective effects
(9–11).
The autoimmune polyendocrinopathy type 1 syndrome
(APS1 also known as APECED) is an autosomal recessive,
monogenic form of human autoimmunity, characterized
by autoimmune destruction of multiple endocrine organs
and defective cell-mediated immunity (12,13). Affected
individuals are diagnosed as having two of three clinical
manifestations, including Addison’s disease, hypoparathy-
roidism, and chronic mucocutaneous candidal infections.
However, other syndromes, including alopecia, exocrine
pancreatic deﬁciency, hypothyroidism, premature ovarian
failure, vitiligo, Sjogren’s syndrome, and type 1 diabetes
could manifest in affected patients (13). In 1997, an
autoimmune regulator (AIRE) gene, which underlies
APS1, was identiﬁed by positional cloning strategies on
chromosome 21q22 (14,15). The AIRE protein plays a
central role in regulating tissue-restricted antigen expres-
sion in medullary thymic epithelial cells. More than hun-
dreds of tissue-restricted antigens are believed to be
modulated in the thymus (16). Ectopic expression of
tissue-restricted antigens could trigger self tolerance,
whereas lack of expression could lead to autoimmunity.
Insulin transcript analysis of individuals with class I or
class III haplotype revealed that class III subjects exhib-
ited higher expression levels of insulin than class I sub-
jects in thymus (7,8). A recent study suggested that the
risk of autoimmune diabetes in autoimmune polyendocri-
nopathy-candidiasis-ectodermal dystrophy (APECED) is
associated with short alleles of the 5-insulin VNTR (17).
Therefore, we hypothesized that the AIRE protein may
function as a regulator of the insulin gene through the
VNTR region. In the present study, we show that AIRE
regulates insulin promoter activity mediated through the
INS-VNTR element. The class III VNTR haplotype induces
far greater insulin transcript expression than the class I
VNTR haplotype and/or the insulin basal promoter alone.
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expression in human thymus that dictates subsequent
tolerance induction.
RESEARCH DESIGN AND METHODS
Constructs. A PCR amplicon from the human insulin basal promoter region
was cloned into a promoterless luciferase vector, pGL3-Basic (Promega) as
pINS-basal. Based on this construct, six individual class I VNTR alleles,
including their 5-ﬂanking regions of about 1.1 kb, were ﬁrst PCR ampliﬁed
from individual human genomic DNA samples and subcloned into the pINS-
basal construct to create the luciferase reporter construct series referred to as
TD, HM, PQ, PW, KE, and RC (genomic DNA samples were obtained from
Human Biological Data Interchange, Philadelphia, PA). The insert sequence of
these constructs corresponds to the same genomic DNA on human chromo-
some 11p15.5, which includes the 5-ﬂanking region, VNTR, and the basal
insulin promoter. The primer sequences used for cloning are listed as follow:
INSpF, GACTCGAGACAGCAGCGCAAAGAGCCC; INSpR, CTTAAGCTTG
CAGCCTGTCCTGGAGGGC; VNTR-5, TACACGCTGCTGGGATCCTGGATCT;
VNTR-3, CTTGGAACAGACCTGCTTGA. The luciferase reporter vector for
the class III VNTR was constructed from a HI-3 clone (18). An artiﬁcial class
III construct was assembled by linking four class I VNTRs 5-upstream of the
human insulin basal promoter sequentially. The 1.1 kb sequence 5-upstream
of the VNTR was deleted during the cloning process. Both ends of the artiﬁcial
class III construct were conﬁrmed by DNA sequence analysis. All of the
PCR-generated amplicons were fully sequenced before use in any functional
assay. For the heterologous promoter study, the insulin basal promoter was
replaced by a SV40 promoter or SV40 promoter and enhancer for use in the
reporter assays. A complete set of reporter construct without the 1.1 kb region
were also constructed and described in Fig. 3A.
Luciferase reporter assay. HIT cell line (ATCC) was grown in low-glucose
Dulbecco’s modiﬁed Eagle’s medium supplemented with 10% FBS. The human
thymic epithelial cell (hTEC) line derived from cortical epithelium (19) was
cultured in RPMI 1,640 medium supplemented with 10% FBS. The primary
thymic epithelial cells from E16–18 rat fetal thymi were isolated and cultured
as previously described (20). Luciferase assays were performed in a 24-well
plate format using Lipofectamine 2000 according to the manufacturer’s
instructions (Invitrogen). For all of the constructs assayed, equal moles of
promoter equivalent were used (50 ng). Luciferase activities were normal-
ized with a cotransfected null-Renilla plasmid (2 ng) (Promega). Since
endogenous AIRE protein is not detected in the hTEC cell line (21) or
transfection-competent rat primary thymic epithelial cells, an exogenous
source of AIRE or control -galactosidase (-gal) was introduced into the
cells using a mammalian expression vector (50 ng). Several passages of freshly
cultured primary cells were maintained until the cells became competent for
transfection. Luciferase activities were measured using the Dual-Glo Lucif-
erase Assay kit (Promega). Activities were based on three to six experiments,
performed in duplicate or triplicate wells for each sample, and either one
representative result or an average of all the experiments was presented.
Western blot analysis. In parallel with the luciferase reporter gene assay,
separate wells of samples were collected to verify the expression of AIRE
protein with a goat anti-AIRE antibody that recognizes the epitope 159-172
amino acids in AIRE protein (Abcam). In addition, a second rabbit antibody
recognizes the epitope 246-545 amino acids in AIRE protein (Santa Cruz) was
used to detect the immunoprecipitated AIRE proteins. The molecular weight
of wild-type AIRE is 60 kDa. Signals were visualized using a chemilumines-
cence kit (Pierce). Equal sample loading on all the Western blots was
conﬁrmed by an anti--actin antibody (Sigma) that recognizes a protein with
a molecular weight of 43 kDa.
INS-VNTR pull-down experiment. Human TEC cells were infected with an
Ad-AIRE viral vector for 2 days. Total cell lysates were prepared in a
pull-down buffer (10 mmol/l Tris buffer, pH 7.5 containing 50 mmol/l NaCl,
1 mmol/l EDTA, and 1 mmol/l DTT) with three freeze-thaw cycles. AIRE
protein expression was detected by Western blot analysis using an
anti-AIRE antibody (Abcam). The insulin basal promoter probe (0.4 kb),
INS-VNTR-class I basal (2.0 kb), and III-basal (3.5 kb) probes were
prepared from the reporter vectors after restriction digestion with KpnI
and HindIII. DNA probes were radiolabeled at the 5-terminal phosphate
with T4 polynucleotide kinase and -
32P-ATP (Perkin Elmer Life Sciences).
AIRE expressing hTEC cell lysate (100 g) was mixed with 50,000 cpm of
each individual probe in pull-down buffer for6ha troom temperature with
constant rotation. Normal goat IgG or goat anti-AIRE antibody was added
to the mixture for an overnight incubation. The following morning, 50 lo f
50% slurry of salmon sperm DNA-treated protein G-beads was added to the
mixture for a 1-h incubation before being subjected to three washes with
pull-down buffer. The washed beads were digested with proteinase K at
55°C for 1 h and subjected to 1% agarose gel separation. The agarose gel
was dried and exposed to X-ray ﬁlm for probe detection.
RESULTS
Molecular cloning of six novel class I VNTR alleles
and the restriction proﬁles of the class I and III
alleles. IDDM2 or INS is one of the multiple loci that
encode susceptibility to type 1 diabetes, a prototype of
human autoimmunity (10,22–24). INS-VNTR situated 5-
upstream of the INS promoter, is regarded as a causal
variant at the locus after a close correlation was found
between VNTR haplotypes and insulin thymic expression
(7,8). However, comprehensive resequencing of the locus
revealed two polymorphisms that are potentially func-
tional and genetically indistinguishable from the VNTR
(25–27). Therefore, direct evidence is required to support
that the VNTR allele controls insulin transcript expression
in the human thymus. To establish a functional role of the
VNTR in the differential thymic insulin gene expression,
six individual human genomic DNA samples were geno-
typed using the PstI
 polymorphism. The PstI
 (uncut by
PstI) polymorphism is in strong linkage disequilibrium
with the diabetes-predisposing class I allele and PstI
	 (cut
by PstI) with diabetes-protective class III VNTR haplo-
types (10). The insulin gene locus at 11p15.5 spanning the
VNTR region was PCR ampliﬁed and digested with PstIt o
determine the haplotype. Class I homozygous individuals
will display a single 290 bp band; class III homozygous
individuals will display two bands 200 and 90 bp; and class
I/III heterozygous individuals display three bands 290, 200,
and 90 bp in size. Of the six DNA samples analyzed,
samples TD and KE are heterozygous class I/III and the
other four are homozygous class I (Fig. 1A). To determine
the relative repeat number of each individual DNA sample,
a NcoI/BglII double restriction endonuclease digest was
performed. Each sample contains a 450, 230, and 100 bp
band as shown in the schematic diagram in Fig. 1C. Using
the approximate size of the class I VNTR band, the number
of repeat units was estimated (Fig. 1D). Finally, sequence
analysis revealed the exact number of repeat units con-
tained in each of the unique human DNA samples and are
shown according to the convention established by Ower-
bach and Gabbary (24) (Fig. 1E).
IDDM2-VNTR locus transduces a quantitative insulin
expression signal in the presence of AIRE. To directly
dissect any transcriptional activity contributed by the
VNTR alleles, we made a set of reporter constructs bearing
the VNTR sequences and excluding the two other putative
causal variants, 	23 Hph I and 1,140 A/C in the INS
locus (Figs. 1 and 3A). Because of the selective tissue
expression of the insulin gene, we ﬁrst tested the class I or
class III VNTR-basal insulin luciferase reporter constructs
in a hamster pancreatic -cell line, HIT. Consistent with
previous reports, the class I VNTR construct activity was
approximately twofold higher than the class III VNTR
constructs in the HIT cells (Fig. 2A, left panel). The
luciferase data conﬁrmed the previous observation that
the type 1 diabetes susceptible shorter class I VNTR (most
commonly 30–40 repeats) was associated with a 1.5- to
3-fold higher insulin expression than the class III VNTR in
the pancreas (5,10), although inconsistent results have
been reported (4) and discussed (10).
We artiﬁcially overexpressed AIRE in HIT cells to
examine the responses of class I and III VNTRs. In the
presence of AIRE, both classes of VNTR display similar
activities, with the class I VNTR being slightly higher than
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an involvement of the autoimmune regulator (AIRE) in the
promiscuous expression of insulin in human thymus
(28,29), whereas thymus-speciﬁc deletion of insulin in-
duces autoimmune diabetes (30). Nevertheless, how the
IDDM2 locus transduces a differential expression signal in
thymus in the context of AIRE remains to be elucidated.
In contrast to the pattern in pancreas, insulin expression
in thymus was reversed, with an average threefold in-
crease of class III over class I alleles, as represented by the
luciferase activity driven by six different class I and one
class III haplotypes in a nontransformed human thymic
epithelial cell line (hTEC) (19) (Fig. 3B and C). This
observation suggests that the diabetes susceptible class I
VNTR might predispose individuals to type 1 diabetes by
lowering insulin expression in the thymus and rendering
less tolerance induction. Evidently, without the other two
polymorphisms, the VNTR alone accounts for quantitative
expression of insulin, which is consistent with the report
that 	23 Hph I, one of the two SNPs, did not play a
signiﬁcant role in thymus (31). Additionally, we conﬁrmed
the independent effect of the VNTR using shorter con-
structs lacking the 1.1 kb 5-ﬂanking regions of the poly-
morphism (Fig. 3F and G). In addition to the hTEC line,
primary epithelial cells dissected from fetal rat thymus
(E16-18) were transfected with the same set of constructs,
and the results conﬁrmed the expression proﬁle observed
in the human cell line (Fig. 3D and E). Remarkably, the
observed expression pattern persisted only in the pres-
ence of AIRE (Fig. 3H). When a control -gal expression
plasmid was administered, the differential expression sig-
nal transduced by the INS-VNTR/IDDM2 locus was totally
lost and the insulin expression driven by either allele
decreased to a basal level (Fig. 3B and D). This line of
evidence warrants further investigation of AIRE regulation
in the context of the VNTR for insulin quantitative expres-
sion in thymic epithelial cells. Since there is only one
natural class III DNA construct available for the compar-
ison study with the six class I VNTR constructs, we further
assembled an artiﬁcial class III construct (162 tandem
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FIG. 1. Six novel class I VNTR alleles and the restriction proﬁle of the class I and III alleles of the constructs. A: Six human genomic DNA samples
were genotyped using the 1,127 PstI polymorphism. PstI
 (uncut by PstI) and PstI
 (cut by PstI) variants are in strong linkage disequilibrium
with diabetic class I and nondiabetic class III VNTR haplotypes, respectively (10). By designing a pair of primers (5-TAAATGCAGAAGCGTG
GCATTGTGGAAC-3 and 5-CTGCATGCTGGGCCTGGCCGG-3), the PCR products ampliﬁed from genomic DNA were digested with PstIt o
generate a single band of 290 bp from class I homozygotes; two bands of 200 bp and 90 bp from class III homozygotes; and three bands of 290 bp,
200 bp, and 90 bp from I/III heterozygotes. TD and KE are heterozygous (I/III) and the other four are homozygous class I. PstI  and  are control
DNA of class I and class III homozygotes, respectively. B: Restriction proﬁle of the VNTR alleles contained in the reporter gene constructs. NcoI
and BglII were used. C: Schematic explanation for the proﬁle shown on the gel B or quantitated in table D. The band sizes are indicated by base
pairs and marked by N (NcoI) and B (BglII); 230  VNTR in C corresponds to VNTR in B or restriction proﬁle in D. D: Estimation of the sizes
of individual VNTR alleles. E: Sequence of six class I VNTR alleles in the format of repeat unit array and according to the convention set by
previous reference (24). The number of repeat units is shown to the right of each sequence.
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transcriptional activities from class III versus class I VNTR
are due to the number of tandem repeats. As shown in
supplementary Fig. 2 in the online appendix available at
http://diabetes.diabetesjournals.org/cgi/content/full/
db10-0255/DC1, artiﬁcial class III displays higher activity
than the natural class III construct (140 tandem repeats).
Additionally, this construct also displays a higher activity
in the no AIRE setting, probably caused by the deletion of
the 5-upstream 1.1 kb sequence of the VNTR (similar to
Fig. 3F).
VNTR responded sensitively and differentially to
AIRE in a human thymic epithelial cell line. Next, we
determined how the class I or class III VNTR allele
responded to an increasing dosage of AIRE expression
plasmid. Each VNTR haplotype transduced a sensitive and
differential signal in the hTEC line. As little as 10 ng of the
AIRE expression plasmid generated a differential re-
sponse between class I (PQ) and class III VNTRs (Fig. 4A).
In the presence of increasing amounts of AIRE protein, the
insulin expression driven by the VNTR increased until a
plateau was reached. The difference between the two
classes of haplotypes was consistently about threefold at
each dose tested, except at the zero dose (Fig. 4A). The
level of AIRE protein expression was veriﬁed with an
AIRE antibody by Western blot (Fig. 4B). Additionally, we
chose the natural class III and the artiﬁcial class III paired
with two other class I (HM and RC) constructs to perform
the dosage response curves (supplementary Fig. 3). Simi-
larly, class I VNTRs response to AIRE is much lower than
both natural and artiﬁcial class III VNTRs.
AIRE regulates the insulin promoter activity medi-
ated through the INS-VNTR element. In the presence of
AIRE, the insulin basal promoter alone (	365 bp) displays
relatively low activity in the human TEC and rat primary
TEC (Fig. 5A and B). The class I VNTR is two to threefold
higher relative to the insulin basal promoter activity,
whereas the class III VNTR increases seven to ninefold
over the insulin basal promoter activity, suggesting that
the AIRE transcriptional regulator could activate the INS-
VNTR sequence in the context of the insulin basal pro-
moter. To validate the interaction between the AIRE
protein and the VNTR sequence, we performed a DNA-
protein pull-down experiment using Adenovirus-AIRE
transduced hTEC cell lysate and radiolabeled DNA probes
(50,000 cpm) derived from the insulin basal promoter, class
I-VNTR-INS-basal promoter, and class III-VNTR-INS-basal
promoter sequences (Fig. 5C). Both class I and III DNA
probes were pulled-down by the anti-AIRE antibody. A very
weak signal, if any, was detected with the insulin basal
promoter probe. This result suggests that AIRE protein can
interact directly or indirectly through the recruitment of a
transcriptional complex to bind the VNTR sequences.
The VNTR is located 365 bp 5-upstream of the human
insulin basal promoter. We designed experiments to eval-
uate whether the VNTR functions in an insulin promoter-
speciﬁc fashion or if it could function effectively with a
heterologous promoter and/or in combination with other
enhancer elements. A representative class I or III VNTR
was subcloned 5-upstream of the SV40 promoter driven
luciferase vector or the SV40 promoter-enhancer driven
luciferase vector. Cotransfection of the luciferase con-
structs with an AIRE expression vector into the human
TEC showed no effect to the luciferase activity with either
class I or III VNTR in conjunction with the SV40 promoter.
The characteristic activation pattern of class I and III
VNTRs seen when linked directly to the insulin basal
promoter disappeared when the insulin basal promoter
was replaced by the SV40 promoter and/or SV40 promoter/
enhancer (Fig. 5D and E). This result indicates that the
VNTR sequence has to function in conjunction with the
insulin basal promoter to respond to AIRE.
In this paper, we have revealed a novel role of the AIRE
protein with the VNTR region in the establishment of differ-
ential tissue regulation of the insulin mRNA in the thymus.
DISCUSSION
Type 1 insulin-dependent diabetes results from the auto-
immune destruction of the insulin producing  cells of the
pancreas. Type 1 diabetes is a polygenic disease and
multiple susceptibility loci have been mapped (32). A
strong correlation between the variable numbers of tan-
dem repeat (VNTR) or IDDM2 locus and the levels of
insulin mRNA expression in the thymus have been clearly
established (4,5,7,8). The short class I allele is predispos-
ing to type 1 diabetes and is associated with lower thymus
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FIG. 2. Pancreas-based insulin expression pattern associated with the
IDDM2-VNTR locus. In comparison with the activity in thymus, the
pancreatic insulin expression pattern, represented by the luciferase
reporter activity, was conﬁrmed in a HIT cell line (A and B). An
average of 1.58-fold increase was observed in reporter activities driven
by class I over class III VNTR haplotypes. The class I activity was
expressed as an average of six constructs. The class III activity was
expressed as an average of three experiments from one construct. The
constructs assayed are the same set of reporter constructs as those
used in the hTEC line or rat primary cells in Fig. 3. Both class I and III
reporter constructs respond to the addition of AIRE similarly.
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FIG. 3. IDDM2-VNTR locus transduces a quantitative insulin expression signal
in the presence of AIRE. A: Diagrammatic representation of the TH-INS-IGF2
interval on chromosome 11p15.5. INS or IDDM2 locus is bordered by TH
(tyrosine hydroxylase) and IGF2 (insulin-like growth factor 2) loci. The three
polymorphisms are designated by their positions with respect to the ﬁrst base
of the INS start codon that is represented by a solid triangle and marked as
1. The allelic variations at the VNTR begin at 603, positioned immediately
before the basal promoter. The average length of a class I VNTR is 0.5 kb
among the alleles we cloned and the class III used is 2.0 kb. A gray arrow
depicts the basal insulin promoter region (365 bp) and open boxes denote the
three insulin exons. The black bold lines represent the regions cloned into the luciferase reporter constructs including the VNTR, its
5-ﬂanking 1.1 kb region, the basal insulin promoter, and excluding the other two polymorphisms. The longer version bearing the 5-ﬂanking
1.1 kb in addition to the VNTR region and basal promoter construct, as well as a shorter construct without the 1.1 kb 5-ﬂanking region, were
analyzed. B: A luciferase reporter gene is driven by class I or class III VNTR with insulin basal promoter (50 ng) and transfected in a hTEC
line. Six class I and one class III haplotypes were tested. The relative activities both without (-gal control) and with exogenous AIRE (50
ng) are shown. The class I activity was expressed as an average of six constructs. The class III activity was expressed as an average of three
experiments from one construct. C: Detailed activities of each individual VNTR allele in the presence of AIRE were tabulated. D and E: The
same set of constructs was assayed using rat primary thymic epithelial cells following the same strategy as in B and C. F and G: To rule out
the possibility that the upstream 5-ﬂanking genomic region (1.1 kb) might contribute to the differential insulin expression in thymus,
another set of constructs was made by removing this region (A) and assaying in the hTEC line. The average difference in thymic expression
is consistently a threefold increase of class III over I VNTR haplotypes. H: Western blot analysis to verify AIRE expression in the transfected
cell line. As a loading control, -actin was used.
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and associated with three to fourfold higher thymic insulin
expression. How this region contributes to this thymic
expression pattern has not been directly tested. The
autoimmune regulator, AIRE, has been shown to direct
the expression of hundreds of tissue-speciﬁc antigens in
the thymus and is crucial for establishment of immune
tolerance (16). To deﬁnitively establish a role of the VNTR
in insulin gene regulation in thymus, both class I and III
VNTRs were cloned and tested in reporter gene studies.
Our cloning strategy spanning the VNTR region of the
INS locus ﬁrst excluded the two additional polymorphisms
(	23 Hph I and  1,140 A/C) that are present within the
IDDM2 locus and may contribute to the differential insulin
levels in the thymus. Without these two polymorphisms,
the VNTR alone accounts for quantitative expression of
insulin. We also removed a 1.1 kb 5-upstream sequence
from the VNTR locus. Reporter constructs that lacked the
1.1 kb 5-upstream genomic region (to the VNTR) showed
a similar promoter activity as the construct that included
this region. These results further conﬁrmed that the thy-
mic insulin gene regulation by AIRE is mediated by the
VNTR.
The transfection studies with the INS-VNTR class I and
III constructs unequivocally show that AIRE controls
differential insulin gene expression through the INS-VNTR
region. To study the role of the AIRE protein in regulating
the insulin promoter via the VNTR region, we further
examined the physical interaction between AIRE and the
VNTR. The AIRE protein has been reported to bind to
target DNA as a homodimer or a tetramer, but not a
monomer. An oligonucleotide library screen showed that
AIRE protein bound to two nucleotide sequences,
TTATTA and two tandem repeats of ATTGGTA (33). It is
difﬁcult to envision that the AIRE protein recognizes a
speciﬁc binding sequence present in hundreds or thou-
sands of target gene promoter sequences. Particularly,
the AIRE binding site is not found in the INS-VNTR region.
Additionally, our data show that the insulin basal pro-
moter region in conjunction with the VNTR is required for
regulation by AIRE protein. Intriguingly, linkage of the
INS-VNTR class I or class III VNTR region with a heterol-
ogous promoter sequence resulted in the complete loss of
AIRE transcriptional regulation. Therefore, it is likely that
AIRE must interact with a protein or complex that is
formed on the basal insulin promoter to modulate insulin
gene expression in the thymus. We speculate that AIRE’s
binding to the target genes may rely on its interaction with
a speciﬁc chromatin structure. Other studies have shown
that AIRE recruits CREB-binding protein, positive tran-
scription elongation factor b, and interacts with target
genes lacking methylated histone H3K4 to regulate tissue-
restricted antigen expression in the thymus (34–36). Re-
cent studies reported that AIRE protein could partner with
four major functional classes: nuclear transport, chroma-
tin binding/structure, transcription, and premRNA pro-
cessing for targeting and inducing peripheral tissue self-
antigen (37). Additionally, DAXX represents another newly
discovered AIRE-interacting protein (38). A recent review
article described the molecular mechanisms of central
tolerance, focusing on the transcriptional regulation by
AIRE (39). Although this paper discussed the general
mechanisms of how the AIRE protein could interact with
multiple target genes, it suggests a sharing of a common
transcriptional complex to exert its activation activities.
The insulin basal promoter has been identiﬁed as a target
for AIRE regulation, but these constructs always lacked
the VNTR region. In response to AIRE, our data show that
in the presence of the VNTR sequence (as in the human
insulin gene locus) insulin basal promoter activity is
signiﬁcantly enhanced in hTECs. Labeling of the basal
insulin promoter, class I and class III basal insulin pro-
moter regions and incubation with an AIRE-expressing
hTEC cell lysates unambiguously showed preferential
binding of the AIRE protein with the VNTR containing
fragments (Fig. 5C). The tandem repeat regions of the
insulin VNTR have been shown to form G-quadruplex
structures (40). The enhanced regulation of the class III
constructs is most likely due to the larger number of
tandem repeats forming a more stable intramolecular
secondary structure that is required for AIRE protein
binding and formation of a transcriptional complex. We
have constructed an artiﬁcial class III VNTR from four
different copies of class I VNTR sequences derived from
patient samples. As expected, the artiﬁcial class III VNTR
(162 tandem repeats) demonstrated a higher transcrip-
tional activity as compared with the natural class III VNTR
(140 tandem repeats) and exhibited approximately three-
fold higher activity than class I VNTR (supplementary Fig.
2). Together, we show that the AIRE protein is capable of
selectively pulling-down the VNTR insulin basal promoter
sequence. Deﬁnitively, these data support the physical
interaction between AIRE and the INS-VNTR, but we
cannot rule out the involvement of other cellular compo-
nents that may be involved in mediating this interaction.
In summary, we reveal a dual control mechanism gov-
erning the insulin quantitative expression in thymus that
may account for part of the genetic predisposition ob-
served in type 1 diabetic patients. AIRE-mediated differ-
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locus in the thymus may inﬂuence tolerance and suscep-
tibility to type 1 diabetes. A similar mechanism was also
reported for myasthenia gravis, another autoimmune dis-
ease (21). These ﬁndings may together suggest a com-
monly adopted regulation strategy that, in addition to
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FIG. 5. AIRE regulates the insulin promoter activity mediated through the INS-VNTR element. A and B: Insulin basal promoter, VNTR-class I-INS-basal
and VNTR-class III-INS-basal vectors demonstrated differential promoter activities in both hTEC and rat primary TEC in response to AIRE. C: DNA
probes derived from insulin basal promoter (0.4 kb), VNTR-class I-INS-basal (2.0 kb), and VNTR-class III-INS-basal (3.5 kb) were radiolabeled with T4
polynucleotide kinase and -
32P-ATP as shown in the input lanes. An Ad-AIRE transduced hTEC total lysate (100 g) was mixed with 50,000 cpm of
each radiolabeled DNA probe for6ha troom temperature and subsequently added 1 g of goat anti-AIRE antibody for an overnight incubation. The
immune complex was precipitated by salmon sperm DNA-treated protein G-agarose beads, washed, and eluted from beads for separation. Normal goat
IgG was used as a negative control. The immunoprecipitated AIRE complexes were veriﬁed using an anti-AIRE antibody. D: VNTR linked to a
heterologous promoter failed to respond to AIRE. The insulin basal promoter was replaced by a SV40 promoter in a reporter construct. Transfection
of the construct lacking the insulin basal promoter with the AIRE expression vector in human TEC was measured for luciferase reporter activity. E:
Addition of a SV40 enhancer to the construct greatly enhanced SV40 promoter activity, but the class I or III VNTR had no effect on the
promoter/enhancer combination. Transfection efﬁciency was normalized with the null-Renilla luciferase reporter vector.
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genes, encode hundreds and/or even more than a thousand
tissue-restricted antigens in the human thymus (41).
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